Professional Documents
Culture Documents
Outpatient medical facility 23,000 patients from all 50 states and 75 foreign countries. Collaboration between medical doctors and scientists. Individualized Biochemical Therapy Scientific Research 501c3 Public Charity
Chemistry Database Studies Metallothionein Research Oxidative Damage -- Essential fats -- Vascular tissue -- Immune cells (leukocytes) -- Brain tissue Assays of autism/control brain tissues.
Behavior & ADHD 6,000 Autism 3,700 Schizophrenia & Bipolar 3,600 Depression
About 90 to 150 assays of chemical factors in blood, urine, or hair for more than 6,000 patients More than 1,000,000 separate chemical analyses
Greater than 99% of ASD patients exhibit abnormal Cu and Zn levels in blood. Normally, Cu & Zn are homeostatically controlled by metallothionein proteins. Conclusion: Depressed metallothionein activity is a distinctive feature of autism.
Major biochemical abnormalities observed throughout the autism spectrum. The biochemical imbalances are more severe than those for ADHD, violent behavior, depression, and psychosis. Female autistics have more disordered chemistry than male autistics.
Elevated serum copper Elevated toxic metals Depressed zinc Undermethylation Pyrrole disorder Severe oxidative stress & damage
Depressed Methionine and SAMe Elevated SAH and Adenosine High Urinary Isoprostanes Depressed Cysteine and Glutathione Low Selenium Levels Depressed Ceruloplasmin Elevated Levels of Free-Radicals
1.
2.
3.
Conclusion: Autism is a condition of oxidative stress An oxidative stress model can explain most symptoms of autism Oxidative stress has become a leading focus of autism research.
Conclusion: Autistics exhibit excessive levels of loosely bound or free-radical copper (high oxidative stress).
3.
Depletes metallothionein & glutathione Associated with inflammation & excessive oxidative stress Can cause abnormal neurotransmitter levels.
.5 2 .5 2 .5 0 .5 0 Autistics Controls
Metallothionein
Required for development of brain cells, Primary filter for Hg, Pb, and other metal toxics at intestinal and blood/brain barriers, Required for homeostasis of Cu and Zn, Supports immune function.
MT is a magnet for mercury, but MT activity is weak in autism-spectrum children.
Short, dense, undeveloped brain cells, Abnormalities observed primarily where MT levels are highest (amygdala, hippocampus, Purkinje cells, inferior olives, and pineal gland).
MT-3 assists in the pruning of brain cells, which makes space for growth of new cells, MT-1 and MT-2 participate in the natural growth (development) of brain cells, MT-3 is the primary agent for termination of growth of fully-developed brain cells.
GSH is first line of defense against Hg, Pb, etc, but has limited capacity for toxic metals. When > 10% of GSH is bound to toxic metals, additional toxics are transferred from GSH to MT. Se increases kinetics of the GSH/MT antioxidant system by more than 50%. For major exposures, most toxic metals depart the body bound to MT.
MT-Promotion Therapy
Formulation of 22 nutrients that promote genetic expression or functioning of MT, including Zinc, Glutathione, and Selenium, Aimed at completion of brain maturation to enable gains in cognition, speech, and socialization, Has resulted in higher frequency of autism recovery at Pfeiffer Treatment Center.
U.S. Patent 7,232, 7 (issued June, 2007)
Published in October, 2006. Archives of Neurology; Vol. 63:1161-1164. Authors Pratico, Walsh, McGinnis, and Yao. Findings: Elevated oxidative damage to fats and vascular tissues for autistic subjects, compared to controls.
Autisti s ntr ls 1 0 iP
American Journal of Biotechnology and Biochemistry; 4(2):61-72, 2008. Authors: Evans, McGinnis, Walsh, Perry, Salomon, Lewis, et. al. First direct evidence of oxidative damage in the autistic brain. Evidence of neurodegeneration in autism
Untreated autism may be neurodegenerative with oxidative damage causing slow, gradual loss of brain cells and IQ. Antioxidant therapy may be necessary throughout the life of a person diagnosed with an autism spectrum disorder.
Most young ASD patients appear quite bright Many successfully treated children become mainstreamed and academic leaders, Most adult autistics exhibit mental severe retardation.
Leukocyte Study
Altered Sulfur Amino Acid Metabolism in Immune Cells of Children Diagnosed with Autism; J. Suh, W. Walsh, W. McGinnis, A. Lewis, and B. Ames.
American Journal of Biochemistry & Biotechnology; 4 (2): 10 -113, 2008.
SAMe levels 36% lower, SAMe/SAH ratios 50% lower, Homocysteine 180% higher, Cysteine 40% lower, GSH 25-60% lower.
Evidence of increased inflammation, increased oxidative stress, and depressed immune function in autism.
2 -3 % of ASD patients exhibit elevated pyrroles. Urine HPL is a good marker for oxidative stress.
Correlation of iP vs. Kp
10 9 8 7 6 5 4 3 2 1 0 0 20 40 iP n / 60 80
c /
Kp
100
Double blind, controlled study, 176 brain tissues & 22 peripheral samples from U. of Marylands Autism Brain Bank, Elemental analysis for 16 elements, including Hg, Pb, Cu, Zn, and Se using high-brilliance photons at ANLs Advanced Photon Source), First elemental assays ever attempted for autism & control brain tissues.
Summary of Findings
Abnormal levels of Ca, S, Fe, Zn in autism brains, The abnormalities are strikingly different for male and female autistics, suggesting that male and female autism may have different genetic origins. Mercury not detected (detection limit of about 100 ppb)
Strong genetic predisposition Onset after environmental insult High oxidative stress Undermethylation Incomplete brain maturation
Strong genetic predisposition -- Higher concordance in siblings -- 60 to 80% concordance in identical twins Influence of environmental factors -- Identical twin concordance not 100% -- Major differences in many identical twins.
ANSWER: The genetic defect involves a weakened ability to cope with environmental stresses
After Birth
Regressive autism. Symptoms depend on developmental stage during insult.
Current consensus that autism results from many genetic defects, rather than from a single gene. A common factor in these genetic defects may be diminished ability to cope with oxidative stress.
Genetic tendency for depressed GSH, MT, Se, etc at intestinal and blood/brain barriers, Inability to prevent Hg, Pb, Cd, and reactive oxygen specie from invading the brain. -- destruction of brain cells -- interruption of brain maturation process
Hypersensitivity to Hg and other toxic metals Hypersensitivity to certain proteins (casein, gluten, etc) Poor immune function Disruption of the methylation cycle Inflammation of the brain & G.I. tract. Depletion of glutathione & metallothionein Excessive amounts of unbound copper
Destroys digestive enzymes needed to break down casein & gluten proteins, Promotes candida/yeast levels, Diminishes Zn levels and production of stomach acid, Produces inflammation, Ineffective barrier to toxic metals at the intestinal mucosa.
Chelation with DMSA, DMPS, EDTA, etc. Methyl B-12 Metallothionein Promotion Transdermal or Injected Glutathione Zn, Se, CoQ-10, Taurine, Vitamins A,C,D,E Alpha Lipoic Acid Risperdal
Mercury Questions
What % of autism cases are triggered by Hg? Can old Hg stay in the brain and cause continuing damage? How serious is the continuing daily exposure to Hg from the environment?
DMSA and DMPS are powerful antioxidants. Chelation can provide antioxidant benefits even if toxic metals are not present. For many patients, the primary benefits of chelation result from antioxidant properties, and not from removal of Hg or other metals. Antioxidant benefits from chelation appear to fade away after about 2-4 weeks.
Rapid removal of toxic metals from peripheral soft tissues & blood, thus preventing their access to the brain, Powerful antioxidant
Limitations of Chelation
Does not fix intestinal or blood/brain barriers, rendering the patient vulnerable to future toxic exposures, Antioxidant benefits are temporary, lasting only 2-4 weeks, May not remove toxic metals from the brain, Complicates Zn management.
Identification & individualized treatment of biochemical imbalances, MT-Promotion therapy, Selective use of adjunct therapies - CF/GF diet - Normalization of intestinal flora - Methylation therapies - Digestive enzymes - etc.
MT Promotion Therapy
Primary Objective:
Advances in cognition, socialization, and speech by enhanced development of immature brain cells and new synaptic connections.
MT Promotion Therapy
Secondary Objectives Elimination of toxic metals & excess Cu Improved immune function Healing of the G.I. tract Reduced food sensitivities Improved behavior control
MT-Promotion Formulation
Generous amounts of Zn and GSH which are essential to induction and functioning of MT, Selenium, Vitamins B-6, C, E, which are known to promote MT, Supplements of the 14 amino-acid constituents of MT in the proportion they exist in MT proteins.
Directly aimed at development of brain cells & new synaptic connections, Potential for permanently correcting the intestinal and blood/brain barriers, Restores the natural (and powerful) body system for coping with toxic metals, Potential for eliminating food sensitivities, yeast problems & intestinal inflammation.
MT Promotion Challenges
Pre-loading with zinc is necessary to prevent temporary side effects, Building up tolerance to the MT Promoter formulation can be a slow process for some children, Commercial lab testing to determine MT status is in its infancy.
Elimination of toxic metals and excessive oxidative stress, Behavioral therapy to stimulate development of brain cells and synaptic connections, MT-Promotion therapy to enable completion of brain maturation.
Summary
Oxidative stress may be the decisive factor in autism-spectrum disorders. Treatment protocols aimed at (1) reduction of oxidative stresses and (2) development of new brain cells and synapses are highly promising. Long-term antioxidant therapy may be needed to prevent loss of brain cells and mental retardation.
THANK YOU!